Trade Names: | |
Synonyms: | |
Status: | Approved (1997) |
Entry Type: | Small molecule |
Molecule Category: | Salt |
UNII: | 8N2L1NX8S3 |
Parent Compound: | EPROSARTAN |
InChI Key | DJSLTDBPKHORNY-XMMWENQYSA-N |
---|---|
Smile | |
InChI |
|
Property Name | Value |
---|---|
Molecular Formula | C24H28N2O7S2 |
Molecular Weight | 520.63 |
AlogP | 4.74 |
Hydrogen Bond Acceptor | 5.0 |
Hydrogen Bond Donor | 2.0 |
Number of Rotational Bond | 10.0 |
Polar Surface Area | 92.42 |
Molecular species | ACID |
Aromatic Rings | 3.0 |
Heavy Atoms | 30.0 |
Action | Mechanism of Action | Reference |
---|---|---|
ANTAGONIST | Type-1 angiotensin II receptor antagonist | FDA |
Mesh Heading | Maximum Phase | Mesh ID | Reference |
---|---|---|---|
Essential Hypertension | 3 | D000075222 | ClinicalTrials |
Resources | Reference |
---|---|
ChEBI | 48409 |
ChEMBL | CHEMBL1200987 |
EPA CompTox | DTXSID7044217 |
FDA SRS | 8N2L1NX8S3 |
KEGG | C07467 |
PubChem | 5282474 |
SureChEMBL | SCHEMBL41396 |
ZINC | ZINC29319828 |